A multidimensional approach in testing nootropic drug effects (Cerebrolysin®)
- 1 March 1990
- journal article
- research article
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 10 (2) , 129-140
- https://doi.org/10.1016/0167-4943(90)90014-w
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Contingent negative variation (CNV) differences between cerebrovascular patients with and without dementiaArchives of Gerontology and Geriatrics, 1988
- Psychostimulants, Analeptics, Nootropics: An Attempt to Differentiate and Assess Drugs Designed for the Treatment of Impaired Brain FunctionsPharmacopsychiatry, 1988
- Cerebral blood flow in severity‐matched Alzheirner and multi‐infarct patientsNeurology, 1987
- Sensitivity of age-decline resistant (“Hold”) WAIS subtests to Alzheimer's diseaseJournal of Clinical and Experimental Neuropsychology, 1985
- The aging human brainAnnals of Neurology, 1985
- Human brain glucose utilization and cognitive function in relation to ageAnnals of Neurology, 1984
- Cortical abnormalities in Alzheimer's diseaseAnnals of Neurology, 1984
- Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomographyAnnals of Neurology, 1984
- “Mini-mental state”Journal of Psychiatric Research, 1975
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960